Internal Medicine, Infectious Disease · Columbus, GA
NPI
1437138872
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
0
Medicare group memberships
Hospitals
2
Hospital affiliations
1711 Buena Vista Rd, Suite 5
Columbus, GA, 31906
Phone (706) 571-3300
Medicare paid, 2024
$89K
1,513 services
Medicare patients, 2024
280
Average age 72
Drug cost, 2024
$9.3M
3,031 prescriptions
Company payments, 2025
$1,007
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Folarin A Olubowale was code 99231 (hospital e&m - subsequent), 705 times for 150 patients. In total Folarin A Olubowale billed 1,513 services in 12 codes, and Medicare paid $89K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99231 Hospital E&M - Subsequent | Facility | 705 | 150 | $37.54 | $26K |
| 99232 Hospital E&M - Subsequent | Facility | 287 | 122 | $59.60 | $17K |
| 99222 Hospital E&M - Initial | Facility | 180 | 160 | $98.99 | $18K |
| 99213 Office E&M - Established | Office | 167 | 83 | $64.34 | $11K |
| 99214 Office E&M - Established | Office | 128 | 90 | $90.89 | $12K |
| 99204 Office E&M - New | Office | 36 | 36 | $125.33 | $4,512 |
By year: 2022 $106K for 1,885 services; 2023 $121K for 2,153 services; 2024 $89K for 1,513 services.
Medicare prescription drug claims, 2024
In 2024, the drug Folarin A Olubowale prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 574 prescriptions and refills. In total Folarin A Olubowale wrote 3,031 Medicare prescriptions that cost $9.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 574 | 574 | 63 | $2.3M |
| Dovato Dolutegravir Sodium/Lamivudine | 136 | 136 | 14 | $410K |
| Atorvastatin Calcium Generic | 124 | 274 | 33 | $724 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 89 | 89 | 11 | $338K |
| Nifedipine Er Nifedipine | 82 | 160 | 20 | $1,361 |
| Amlodipine Besylate Generic | 74 | 172 | 18 | $360 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 67 | 71 | Under 11 | $344K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 65 | 73 | 23 | $338 |
| Tivicay Dolutegravir Sodium | 58 | 58 | Under 11 | $209K |
| Gabapentin Generic | 56 | 65 | Under 11 | $477 |
| Kalbitor Ecallantide | 52 | 52 | Under 11 | $3.6M |
| Lisinopril-Hydrochlorothiazide Lisinopril/Hydrochlorothiazide | 51 | 109 | 12 | $301 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 51 | 51 | Under 11 | $210K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 46 | 54 | 14 | $1,194 |
| Cabenuva Cabotegravir/Rilpivirine | 43 | 80 | Under 11 | $309K |
Brand drugs: - claims; generic drugs: 1,637 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Folarin A Olubowale $1,007 ($1,007 in general payments such as food, travel and fees) from 6 companies. The largest payer was Gilead Sciences, Inc. with $414.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.